NICE recommendations are for ‘pelvic imaging’ in the form of MRI or CT (where MRI is contraindicated) only in the high risk prostate cancer population (PSA >20ng/ml, Gleason score 8–10 or clinical T3/T4 disease).25 Here, KLK3 is linked to Familial prostate cancer.